Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Joe Mendiola Killed in Pedestrian Crash at West and Shields Avenues


Victim Hit by Car in Fatal Fresno Accident

Fresno, CA (March 2, 2020) – A man was killed in a pedestrian crash in Fresno. The fatal accident occurred on the evening of March 2 at West and Shields avenues.

Fresno resident Joe Mendiola, 67, was crossing the intersection when he was hit by a car driven by a woman. Mendiola was taken to a local hospital, where he later died. It is unknown if the driver or her three children inside the car were injured. 

Our heartfelt condolences go out to the friends and loved ones of Joe Mendiola.

#Fresno

#93705


October 30, 2019

2 Injured in Crash on Highway 54 Near Interstate 805

3 Vehicles Involved in National City Accident...


April 1, 2020

1 Killed, 1 Injured in Crash on Highway 18 Near Apple Valley Road

4 Vehicles Involved in Fatal Apple Valley Accident...


January 27, 2020

1 Killed, 1 Injured in Crash on Interstate 5 Near Charter Way

Vehicle Goes Off Road in Fatal Stockton Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.